SERENATIS BIO LIMITED

  • Overview
  • Summary
  • Purpose
  • Address
  • Accounts
  • Confirmation Statement
  • Filings
  • Officers
  • Persons with significant controls
  • Data Source
  • Overview

    Company NameSERENATIS BIO LIMITED
    Company StatusActive
    Legal FormPrivate limited company
    Company Number 15944501
    JurisdictionEngland/Wales
    Date of Creation

    Summary

    Has Super Secure PSCsNo
    Has ChargesNo
    Has Insolvency HistoryNo
    Registered Office is in DisputeNo

    What is the purpose of SERENATIS BIO LIMITED?

    • Research and experimental development on biotechnology (72110) / Professional, scientific and technical activities

    Where is SERENATIS BIO LIMITED located?

    Registered Office Address
    66 Devonshire Road
    CB1 2BL Cambridge
    England
    Undeliverable Registered Office AddressNo

    What are the latest accounts for SERENATIS BIO LIMITED?

    OverdueNo
    Next Accounts
    Next Accounts Period End OnSep 30, 2026
    Next Accounts Due OnJun 30, 2027
    Last Accounts
    Last Accounts Made Up ToSep 30, 2025

    What is the status of the latest confirmation statement for SERENATIS BIO LIMITED?

    Last Confirmation Statement Made Up ToSep 08, 2026
    Next Confirmation Statement DueSep 22, 2026
    Last Confirmation Statement
    Next Confirmation Statement Made Up ToSep 08, 2025
    OverdueNo

    What are the latest filings for SERENATIS BIO LIMITED?

    Filings
    DateDescriptionDocumentType

    Micro company accounts made up to Sep 30, 2025

    4 pagesAA

    Confirmation statement made on Sep 08, 2025 with updates

    4 pagesCS01

    Change of details for Dr Nicolas Thierry Sireau as a person with significant control on Jul 08, 2025

    2 pagesPSC04

    Statement of capital following an allotment of shares on Jun 27, 2025

    • Capital: GBP 1.39546
    3 pagesSH01

    Registered office address changed from 53 Byron Square Trumpington Cambridge CB2 9JL England to 66 Devonshire Road Cambridge CB1 2BL on Jun 24, 2025

    1 pagesAD01

    Statement of capital following an allotment of shares on May 15, 2025

    • Capital: GBP 1.33897
    3 pagesSH01

    Sub-division of shares on May 09, 2025

    6 pagesSH02

    Resolutions

    Resolutions
    2 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    capital

    Resolution of allotment of securities

    RES10
    capital

    Resolution of varying share rights or name

    RES12
    capital

    Resolutions

    Re: subdivision 09/05/2025
    RES13
    incorporation

    Resolution of adoption of Articles of Association

    RES01
    capital

    Resolution of removal of pre-emption rights

    RES11

    Memorandum and Articles of Association

    25 pagesMA

    Appointment of Susanne Stuffers as a director on May 09, 2025

    2 pagesAP01

    Appointment of Dr Natalie Pankova as a director on May 09, 2025

    2 pagesAP01

    Incorporation

    14 pagesNEWINC
    Associated Filings
    CategoryDateDescriptionType
    capitalSep 09, 2024

    Statement of capital on Sep 09, 2024

    • Capital: GBP 1
    SH01
    incorporationSep 09, 2024

    Model articles adopted

    MODEL ARTICLES

    Who are the officers of SERENATIS BIO LIMITED?

    Officers
    NameAppointed OnResigned OnRoleAddressCompany IdentificationCountry of ResidenceNationalityDate of BirthOccupationNumber
    CAVALLA, David John, Dr
    Devonshire Road
    CB1 2BL Cambridge
    66
    England
    Director
    Devonshire Road
    CB1 2BL Cambridge
    66
    England
    EnglandBritish37933740001
    PANKOVA, Natalie, Dr
    24 Eversholt Street
    NW1 1AD London
    6th Floor
    England
    Director
    24 Eversholt Street
    NW1 1AD London
    6th Floor
    England
    EnglandBritish275907070002
    SIREAU, Nicolas Thierry, Dr
    Devonshire Road
    CB1 2BL Cambridge
    66
    England
    Director
    Devonshire Road
    CB1 2BL Cambridge
    66
    England
    EnglandBritish105972830004
    STUFFERS, Susanne
    Eiganesveien 95
    4009 Stavanger
    Eiganesveien 95
    Norway
    Director
    Eiganesveien 95
    4009 Stavanger
    Eiganesveien 95
    Norway
    NorwayNorwegian335866240001

    Who are the persons with significant control of SERENATIS BIO LIMITED?

    Persons with significant controls
    NameNotified OnAddressCeased
    Dr Nicolas Thierry Sireau
    Devonshire Road
    CB1 2BL Cambridge
    66
    England
    Sep 09, 2024
    Devonshire Road
    CB1 2BL Cambridge
    66
    England
    No
    Nationality: British
    Country of Residence: England
    Natures of Control
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the shares in the company.
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the voting rights in the company.
    • The person holds the right, directly or indirectly, to appoint or remove a majority of the board of directors of the company.
    Dr David John Cavalla
    Devonshire Road
    CB1 2BL Cambridge
    66
    England
    Sep 09, 2024
    Devonshire Road
    CB1 2BL Cambridge
    66
    England
    No
    Nationality: British
    Country of Residence: England
    Natures of Control
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the shares in the company.
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the voting rights in the company.
    • The person holds the right, directly or indirectly, to appoint or remove a majority of the board of directors of the company.

    Data Source

    • UK Companies House
      The official register of companies in the UK, providing public access to company information such as names, addresses, directors, and financial filings.
    • license: CC0